HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1737387Generated: November 1, 2026
(Methoxycarbonylsulfamoyl)triethylammonium hydroxide → HCID 54469685, compound
https://huagongshe.com/reaction/1737387
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | (Methoxycarbonylsulfamoyl)triethylammonium hydroxide | HCID 11032497 | — |
| Reactant | HCID 53816448 | HCID 53816448 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 54469685 | HCID 54469685 | 51% |
Reaction Steps
A solution of 14.0 g (0.0356 mol) of methyl (S)-2-(7-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-3-ylcarbonylamino)-3-hydroxy-propionate in 250 ml of tetrahydrofuran was treated while gassing with argon with 9.3 g (0.0392 mol) of methoxycarbonylsulphamoyl-triethylammonium hydroxide internal salt (Burgess reagent) according to the method described in Tetr. Letters 1992, 33, 907. The mixture was boiled at reflux for 31/2 hrs. and completely freed from the solvents. The residue was partitioned between dichloromethane and water, extracted and chromatographed over silica gel with ethyl acetate/ethanol 19:1 as the eluent. There were obtained 6.80 g (51%) of methyl (S)-2-(7-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-3-yl)-4,5-dihydro-oxazole-4-carboxylate as white crystals; m.p. 216-218°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05962450 |
|---|
| Source dataset | uspto-grants-1999_10 |
|---|
| ORD ID | ord-d66e43281b684baba708d336a16915ab |
|---|
| Source note | uspto-grants-1999_10 |
|---|